Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biotech patent examiners

Executive Summary

Budgetary constraints make it impossible for the U.S. Patent and Trademark Office to carry out plans to add 120 new biotech patent examiners over the next two years, PTO Group 180 Deputy Director Charles Warren told the seventh annual Biotechnology Law Institute meeting on June 7. The office will now aim for 30 new examiners in FY 1991 and will attempt to add another 50 in FY 1992, Warren said. These additions should bring the Group 180 examiner staff up to 185 by the end of FY 1992.
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS019282

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel